Press release
Deadline on March 8th coming up in Lawsuit for Investors in Tricida, Inc. (NASDAQ: TCDA)
A Deadline is coming up on March 8, 2021 in the lawsuit for certain investors in Tricida, Inc. (NASDAQ: TCDA).
Investors who purchased shares of Tricida, Inc. (NASDAQ: TCDA) have certain options and there are strict and short deadlines running. Deadline: March 8, 2021. NASDAQ: TCDA stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges on behalf of purchasers of Tricida, Inc. (NASDAQ: TCDA) common shares between September 4, 2019 and October 28, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between September 4, 2019 and October 28, 2020, the Defendants made false and/or misleading statements and failed to disclose to investors that Tricida's NDA for veverimer was materially deficient, that accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Tricida, Inc. (NASDAQ: TCDA) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on March 8th coming up in Lawsuit for Investors in Tricida, Inc. (NASDAQ: TCDA) here
News-ID: 2245143 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Tricida
Metabolic Acidosis Market Forecasted for Strong Growth from 2025 to 2032 | Tisen …
The metabolic acidosis market is estimated to be valued at USD 188.7 Mn in 2025 and is expected to reach USD 285.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032.
A new report from CoherentMI, titled "Metabolic Acidosis Market 2025-2032," offers an in-depth examination of the industry, including valuable insights into the Metabolic Acidosis Market's performance. The report covers competitor dynamics, regional…
Metabolic Acidosis Market 2025: Key Trends, Applications, and Technological Adva …
The metabolic acidosis market is estimated to be valued at USD 177.9 Mn in 2024 and is expected to reach USD 265.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.89% from 2024 to 2031.
According to the latest research from CoherentMI, the Metabolic Acidosis Market is projected to experience significant growth between 2025 and 2032. This market intelligence report offers in-depth analysis based on thorough…
Metabolic Acidosis Market Expected to rise, 2034 | Tisento Therapeutics, Tricida …
The Metabolic Acidosis market growth is driven by factors like increase in the prevalence of Metabolic Acidosis, investments in research and development, entry of emerging therapies during the study period 2020-2034.
The Metabolic Acidosis market report [https://www.delveinsight.com/report-store/metabolic-acidosis-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] also offers comprehensive insights into the Metabolic Acidosis market size, share, Metabolic Acidosis epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and…
Chronic Kidney Disease Market Growth Projections 2024-2034: DelveInsight Analysi …
The Key Chronic Kidney Disease Companies in the market include - Tricida, Otsuka Pharmaceuticals, AstraZeneca, and others.
The Chronic Kidney Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Kidney Disease pipeline products will significantly revolutionize the Chronic Kidney Disease market dynamics.
DelveInsight's "Chronic Kidney Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of…
Chronic Kidney Disease Market and Epidemiology 2032: Treatment Market, Therapies …
The Chronic Kidney Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Kidney Disease pipeline products will significantly revolutionize the Chronic Kidney Disease market dynamics.
DelveInsight's "Chronic Kidney Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Kidney Disease, historical and forecasted epidemiology as well as the Chronic Kidney…
Investigation announced for Long-Term Investors in NASDAQ: TCDA shares over poss …
Certain directors of Tricida, Inc. are under investigation concerning potential breaches of fiduciary duties.
Investors who are current long term investors in Tricida, Inc. (NASDAQ: TCDA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: TCDA stocks follows a lawsuit filed against Tricida, Inc. over alleged securities laws violations.…
